Cart
sales@molnova.com
Samatasvir
CAS No. 1312547-19-5
Samatasvir( ATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719 )
Catalog No. M28765 CAS No. 1312547-19-5
Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 597 | Get Quote |
|
| 50MG | 851 | Get Quote |
|
| 100MG | 1152 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSamatasvir
-
NoteResearch use only, not for human use.
-
Brief DescriptionSamatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
-
DescriptionSamatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
-
In VitroSamatasvir (IDX719) retains full activity in the presence of HIV and hepatitis B virus (HBV) antivirals and is not cross-resistant with HCV protease, nucleotide, and nonnucleoside polymerase inhibitor classes.
-
In Vivo——
-
SynonymsATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719
-
PathwayMicrobiology/Virology
-
TargetHCV
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1312547-19-5
-
Formula Weight885.07
-
Molecular FormulaC47H48N8O6S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (56.49 mM)
-
SMILESCOC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1nc2ccc(cc2[nH]1)-c1csc2c(csc12)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@H](NC(=O)OC)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Casper DM, et al. Toward the development of a structurally novel class of chiral auxiliaries: diastereoselective aldol reactions of a (1R,2S)-ephedrine-based 3,4,5,6-tetrahydro-2H-1,3,4-oxadiazin-2-one. Org Lett. 2002 Oct 17;4(21):3739-42.
molnova catalog
related products
-
Pibrentasvir
Pibrentasvir (ABT-530) is a novel and pan-genotypic HCV NS5A inhibitor with EC50 of 1.4-5.0 pM against HCV replicons containing NS5A genotypes 1-6.
-
KIN101
KIN101, an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KIN101 has antiviral activity against RNA viruses, HCV, and RSV.
-
VX-222
A potent and selective, nonnucleoside inhibitor of HCV NS5B polymerase inhibitor with Kd of 17 nM.
